Skip to main content
Top
Published in: Radiation Oncology 1/2018

Open Access 01-12-2018 | Research

Recommendation for the definition of postoperative radiotherapy target volume based on a pooled analysis of patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma

Authors: Xiaofei Zhang, Xi Yang, Jianjiao Ni, Yida Li, Liqing Zou, Li Chu, Xiao Chu, Fan Xia, Zhengfei Zhu

Published in: Radiation Oncology | Issue 1/2018

Login to get access

Abstract

Background

Elective use of radiation therapy to treat regionally involved lymph nodes (LNs) after radical surgery for esophageal squamous cell carcinoma (ESCC) is controversial. We studied metastasis patterns through a pooled analysis of published results to guide post-operative radiotherapy (PORT) target designation.

Methods

We searched the MEDLINE database for literature published from May 1977 to March 2018, and found 14 relevant original studies that included 2738 patients with thoracic ESCC. We calculated probabilities of recurrence and metastasis in local (including anastomoses and tumor bed), LNs and distal areas.

Results

Recurrence rates were 1.88% for local, 13.18% for distal, and 22.16% for LNs. Within LNs, recurrence rates were cervical/supraclavicular: 37.69%, upper mediastinal: 44.30%, middle mediastinal: 21.81%, lower mediastinal: 2.57%, abdominal paraaortic: 25% and upper abdominal: 9.56%. Whereas cervical/supraclavicular and upper mediastinal LNs had the highest recurrence rates, abdominal LNs also had high recurrence rates in patients with lower thoracic ESCC.

Conclusions

PORT volume should include the cervical/supraclavicular and upper mediastinal LNs for all thoracic ESCC, and abdominal paraaortic LNs for lower thoracic ESCC. Anastomoses and tumor beds should not be included in the PORT volume if they are not adjacent to the PORT-LN regions. Upper abdominal LNs might not necessarily be included in the PORT volume for thoracic ESCC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRef
2.
go back to reference Mirinezhad SK, Somi MH, Seyednezhad F, Jangjoo AG, Ghojazadeh M, et al. Survival in patients treated with definitive chemo-radiotherapy for nonmetastatic esophageal cancer in north- West Iran. Asian Pac J Cancer Prev. 2013;14:1677–80.CrossRef Mirinezhad SK, Somi MH, Seyednezhad F, Jangjoo AG, Ghojazadeh M, et al. Survival in patients treated with definitive chemo-radiotherapy for nonmetastatic esophageal cancer in north- West Iran. Asian Pac J Cancer Prev. 2013;14:1677–80.CrossRef
3.
go back to reference Giuli R, Gignoux M. Treatment of carcinoma of the esophagus. Retrospective study of 2,400 patients. Ann Surg. 1980;192:44–52.CrossRef Giuli R, Gignoux M. Treatment of carcinoma of the esophagus. Retrospective study of 2,400 patients. Ann Surg. 1980;192:44–52.CrossRef
4.
go back to reference Katayama A, Mafune K, Tanaka Y, et al. Autopsy findings in patients after curative esophagectomy for esophageal carcinoma. J Am Coll Surg. 2003;196:866–73.CrossRef Katayama A, Mafune K, Tanaka Y, et al. Autopsy findings in patients after curative esophagectomy for esophageal carcinoma. J Am Coll Surg. 2003;196:866–73.CrossRef
5.
go back to reference Xiao ZF, Yang ZY, Miao YJ, et al. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases. Int J Radiat Oncol Biol Phys. 2005;62:82–90.CrossRef Xiao ZF, Yang ZY, Miao YJ, et al. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases. Int J Radiat Oncol Biol Phys. 2005;62:82–90.CrossRef
6.
go back to reference Chen JQ, Zhu J, Pan JJ, et al. Postoperative radiotherapy improved survival of poor prognostic squamous cell carcinoma esophagus. Ann Thorac Surg. 2010;90:435–42.CrossRef Chen JQ, Zhu J, Pan JJ, et al. Postoperative radiotherapy improved survival of poor prognostic squamous cell carcinoma esophagus. Ann Thorac Surg. 2010;90:435–42.CrossRef
7.
go back to reference Chen JQ, Pan JJ, Zheng XW, et al. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2012;82:475–82.CrossRef Chen JQ, Pan JJ, Zheng XW, et al. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2012;82:475–82.CrossRef
9.
go back to reference Zhu Z, Yu W, Li H, et al. Nodal skip metastasis is not a predictor of survival in thoracic esophageal squamous cell carcinoma. Ann Surg Onco. 2013;20(9):3052–8.CrossRef Zhu Z, Yu W, Li H, et al. Nodal skip metastasis is not a predictor of survival in thoracic esophageal squamous cell carcinoma. Ann Surg Onco. 2013;20(9):3052–8.CrossRef
10.
go back to reference Doki Y, Ishikawa O, Takachi K, et al. Association of the Primary Tumor Location with the site of tumor recurrence after curative resection of thoracic esophageal Carcinoma. World J Surg. 2005;29:700–7.CrossRef Doki Y, Ishikawa O, Takachi K, et al. Association of the Primary Tumor Location with the site of tumor recurrence after curative resection of thoracic esophageal Carcinoma. World J Surg. 2005;29:700–7.CrossRef
11.
go back to reference Li C, Zhang F. Characteristics of recurrence after radical esophagectomy with two-field lymph node dissection for thoracic esophageal cancer. Oncol Lett. 2013;5:355–9.CrossRef Li C, Zhang F. Characteristics of recurrence after radical esophagectomy with two-field lymph node dissection for thoracic esophageal cancer. Oncol Lett. 2013;5:355–9.CrossRef
12.
go back to reference Bhansali MS, Fujita H. Pattern of recurrence after extended radical Esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg. 1997;21:275–81.CrossRef Bhansali MS, Fujita H. Pattern of recurrence after extended radical Esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg. 1997;21:275–81.CrossRef
14.
go back to reference Guo X, Mao T, et al. Clinical study on postoperative recurrence in patients with pN1 esophageal squamous cell carcinoma. Thoracic Cancer. 2015;6:146–50.CrossRef Guo X, Mao T, et al. Clinical study on postoperative recurrence in patients with pN1 esophageal squamous cell carcinoma. Thoracic Cancer. 2015;6:146–50.CrossRef
15.
go back to reference Guo X, Mao T, et al. Clinical study on postoperative recurrence in patients with pN0 esophageal squamous cell carcinoma. J Cardiothorac Surg. 2014;9:150.CrossRef Guo X, Mao T, et al. Clinical study on postoperative recurrence in patients with pN0 esophageal squamous cell carcinoma. J Cardiothorac Surg. 2014;9:150.CrossRef
16.
go back to reference Chen X, Chen T-w. Patterns of lymph node recurrence after radical surgery impacting on survival of patients with pT1-3N0M0 thoracic esophageal squamous cell carcinoma. J Korean Med Sci. 2014;29:217–23.CrossRef Chen X, Chen T-w. Patterns of lymph node recurrence after radical surgery impacting on survival of patients with pT1-3N0M0 thoracic esophageal squamous cell carcinoma. J Korean Med Sci. 2014;29:217–23.CrossRef
17.
go back to reference Hiromasa Fujita MD, Teruo Kakegawa MD. Lymph node metastasis and recurrence in patients with a carcinoma of the thoracic esophagus who underwent three-field dissection. World J Surg. 1994;18:266–72.CrossRef Hiromasa Fujita MD, Teruo Kakegawa MD. Lymph node metastasis and recurrence in patients with a carcinoma of the thoracic esophagus who underwent three-field dissection. World J Surg. 1994;18:266–72.CrossRef
18.
go back to reference Gang C, Wang Z. Recurrence patterns of esophageal Cancer after Ivor-Lewis Esophagectomy—a report of 196 cases. Chinese Journal of Cancer. 2006;25(1):96–9. Gang C, Wang Z. Recurrence patterns of esophageal Cancer after Ivor-Lewis Esophagectomy—a report of 196 cases. Chinese Journal of Cancer. 2006;25(1):96–9.
19.
go back to reference Nakagawa S, Kanda T. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical Esophagectomy with three-field lymphadenectomy. J Am Coll Surg. 2004;198:205–11.CrossRef Nakagawa S, Kanda T. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical Esophagectomy with three-field lymphadenectomy. J Am Coll Surg. 2004;198:205–11.CrossRef
20.
go back to reference Cai W-J, Xin P-L. Pattern of relapse in surgical treated patients with thoracic esophageal squamous cell carcinoma and its possible impact on target delineation for postoperative radiotherapy. Radiother Oncol. 2010;96:104–7.CrossRef Cai W-J, Xin P-L. Pattern of relapse in surgical treated patients with thoracic esophageal squamous cell carcinoma and its possible impact on target delineation for postoperative radiotherapy. Radiother Oncol. 2010;96:104–7.CrossRef
21.
go back to reference Natsugoe S, Matsumoto M. Clinical course and outcome after esophagectomy with three-field lymphadenectomy in esophageal cancer. Langenbeck's Arch Surg. 2010;395:341–6.CrossRef Natsugoe S, Matsumoto M. Clinical course and outcome after esophagectomy with three-field lymphadenectomy in esophageal cancer. Langenbeck's Arch Surg. 2010;395:341–6.CrossRef
22.
go back to reference Liu J, Cai X, Liu Q, et al. Characteristics of the local recurrence pattern after curative resection and values in target region delineation in postoperative radiotherapy for lower thoracic esophageal squamous cell cancer. Thoracic Cancer. 2017;8:630–3.CrossRef Liu J, Cai X, Liu Q, et al. Characteristics of the local recurrence pattern after curative resection and values in target region delineation in postoperative radiotherapy for lower thoracic esophageal squamous cell cancer. Thoracic Cancer. 2017;8:630–3.CrossRef
23.
go back to reference Wang X, Luo Y, Li M, et al. Recurrence pattern of squamous cell carcinoma in the midthoracic esophagus: implications for the clinical target volume design of postoperative radiotherapy. OncoTargets and Therapy. 2016;9:6021–7.CrossRef Wang X, Luo Y, Li M, et al. Recurrence pattern of squamous cell carcinoma in the midthoracic esophagus: implications for the clinical target volume design of postoperative radiotherapy. OncoTargets and Therapy. 2016;9:6021–7.CrossRef
24.
go back to reference Tachibana M, Kinugasa S, Shibakita M, Tonomoto Y, Hattori S, et al. Surgical treatment of superficial esophageal cancer. Langenbeck's Arch Surg. 2006;391:304–21.CrossRef Tachibana M, Kinugasa S, Shibakita M, Tonomoto Y, Hattori S, et al. Surgical treatment of superficial esophageal cancer. Langenbeck's Arch Surg. 2006;391:304–21.CrossRef
25.
go back to reference Chen J, Liu S, Pan J, Zheng X, Zhu K, et al. The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma. Eur J Cardiothorac Surg. 2009;36:480–6.CrossRef Chen J, Liu S, Pan J, Zheng X, Zhu K, et al. The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma. Eur J Cardiothorac Surg. 2009;36:480–6.CrossRef
26.
go back to reference Huang W, Li B, Gong H, Yu J, Sun H, et al. Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: a report of 1077 cases. Radiother Oncol. 2010;95:229–33.CrossRef Huang W, Li B, Gong H, Yu J, Sun H, et al. Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: a report of 1077 cases. Radiother Oncol. 2010;95:229–33.CrossRef
27.
go back to reference Ténière P, Hay J-M, Fingerhut A, et al. Postoperation radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet. 1991;173:123–30.PubMed Ténière P, Hay J-M, Fingerhut A, et al. Postoperation radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet. 1991;173:123–30.PubMed
28.
go back to reference Mei ZR, Xiang QC, Wu WJ, et al. Randomized controlled trial of prophylactic radiotherapy for postoperative esophageal carcinoma. Chin J Radiat Oncol. 1997;6:188–9. Mei ZR, Xiang QC, Wu WJ, et al. Randomized controlled trial of prophylactic radiotherapy for postoperative esophageal carcinoma. Chin J Radiat Oncol. 1997;6:188–9.
29.
go back to reference Fok M, Sham JS, Choy D, et al. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery. 1993;113:138–47.PubMed Fok M, Sham JS, Choy D, et al. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery. 1993;113:138–47.PubMed
30.
go back to reference Bédard EL, Inculet RI, Malthaner RA. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer. 2001;91:2423–30.CrossRef Bédard EL, Inculet RI, Malthaner RA. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer. 2001;91:2423–30.CrossRef
31.
go back to reference Nishimura Y, Ono K, Imamura M, et al. Postoperative radiation therapy for esophageal cancer. Radiat Med. 1989;7:88–94.PubMed Nishimura Y, Ono K, Imamura M, et al. Postoperative radiation therapy for esophageal cancer. Radiat Med. 1989;7:88–94.PubMed
Metadata
Title
Recommendation for the definition of postoperative radiotherapy target volume based on a pooled analysis of patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma
Authors
Xiaofei Zhang
Xi Yang
Jianjiao Ni
Yida Li
Liqing Zou
Li Chu
Xiao Chu
Fan Xia
Zhengfei Zhu
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2018
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-018-1199-3

Other articles of this Issue 1/2018

Radiation Oncology 1/2018 Go to the issue